Education
About Us
Working with TipRanks
Follow Us
Intuitive Surgical (ISRG)
NASDAQ:ISRG
ISRG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$425.00 - $616.00
Previous CloseN/A
Volume485.62K
Average Volume (3M)2.16M
Market Cap
$168.48B
Enterprise Value$192.64B
Total Cash (Recent Filing)$5.33B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)65.2
Beta1.21
Next Earnings
Oct 16, 2025EPS Estimate
1.99Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.19
Shares Outstanding358,476,500
10 Day Avg. Volume2,519,492
30 Day Avg. Volume2,160,297
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)11.28
Price to Sales (P/S)22.20
P/FCF Ratio142.20
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue21.06
Enterprise Value/Gross Profit31.61
Enterprise Value/Ebitda59.10
Forecast
1Y Price Target
$600.94Price Target Upside28.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering20
Bulls Say, Bears Say
Bulls Say
New CEO And Business StrategyThere are new areas of focus for the new CEO, new procedure opportunities, and new platforms that enhance the outlook for Intuitive’s business.
Product Launches And Market ExpansionFive transformational product launches expected to inflect, creating an enhanced buying opportunity as the stock is down 28% from a high.
Bears Say
International Market ChallengesOUS placements continue to reflect financial pressures and healthcare spending constraints in several key markets.
Investor ConcernsThe stock ended the day down 6% due to investor concerns about capital, gross margin headwinds, U.S. procedure deceleration, and remanufactured instruments.
Intuitive Surgical News
ISRG FAQ
What was Intuitive Surgical’s price range in the past 12 months?
Intuitive Surgical lowest stock price was $425.00 and its highest was $616.00 in the past 12 months.
What is Intuitive Surgical’s market cap?
Intuitive Surgical’s market cap is $168.48B.
When is Intuitive Surgical’s upcoming earnings report date?
Intuitive Surgical’s upcoming earnings report date is Oct 16, 2025 which is in 35 days.
How were Intuitive Surgical’s earnings last quarter?
Intuitive Surgical released its earnings results on Jul 22, 2025. The company reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.928 by $0.262.
Is Intuitive Surgical overvalued?
According to Wall Street analysts Intuitive Surgical’s price is currently Undervalued.
Does Intuitive Surgical pay dividends?
Intuitive Surgical does not currently pay dividends.
What is Intuitive Surgical’s EPS estimate?
Intuitive Surgical’s EPS estimate is 1.99.
How many shares outstanding does Intuitive Surgical have?
Intuitive Surgical has 358,476,500 shares outstanding.
What happened to Intuitive Surgical’s price movement after its last earnings report?
Intuitive Surgical reported an EPS of $2.19 in its last earnings report, beating expectations of $1.928. Following the earnings report the stock price went down -1.771%.
Which hedge fund is a major shareholder of Intuitive Surgical?
Currently, no hedge funds are holding shares in ISRG
Intuitive Surgical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$600.94 (28.53% Upside)
$600.94 (28.53% Upside)
Blogger Sentiment
Bullish
ISRG Sentiment 68%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 524.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.7%
Last 30 Days ▲ 6.0%
Last 30 Days ▲ 6.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.47%
12-Months-Change
Fundamentals
Return on Equity
16.02%
Trailing 12-Months
Asset Growth
21.10%
Trailing 12-Months
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
ISRG Company Deck
ISRG Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented strong financial and operational performance with notable growth in procedure volumes and successful product launches. However, macroeconomic challenges in international markets and tariff impacts were highlighted as concerns.View all ISRG earnings summariesISRG Revenue Breakdown
66.92% U.S.
33.08% Outside of U.S
ISRG Stock 12 Month Forecast
Average Price Target
$600.94
▲(28.53% Upside)
Technical Analysis
Ownership Overview
0.49% Insiders
24.84% Mutual Funds
16.46% Other Institutional Investors
33.12% Public Companies and Individual Investors